This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ko, S. Articles by Chatterjee, B. Search for Related Content PubMed PubMed Citation Articles by Ko, S. Articles by Chatterjee, B.

Interplay of Nuclear Factor-B and B-myb in the Negative Regulation of Androgen Receptor Expression by Tumor Necrosis Factor

Department of Molecular Medicine/Institute of Biotechnology (S.K., L.S., S.K., C.S.S., B.C.), The University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas 78245; and South Texas Veterans Health Care System (B.C.), Audie L. Murphy Veterans Affairs Hospital, San Antonio, Texas 78229

Address all correspondence and requests for reprints to: Bandana Chatterjee, Ph.D., Department of Molecular Medicine/Institute of Biotechnology, The University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, Texas 78245. E-mail: chatterjee{at}uthscsa.edu.

Increased androgen receptor (AR) levels are associated with prostate cancer progression to androgen independence and therapy resistance. Evidence has suggested that chronic inflammation is closely linked to various cancers including prostate cancer. Herein we show that the proinflammatory cytokine TNF negatively regulates AR mRNA and protein expression and reduces androgen sensitivity in androgen-dependent LNCaP human prostate cancer cells. Decreased AR expression results from transcription repression involving essential in cis interaction of nuclear factor-B (NF-B) with the B-myb transcription factor at a composite genomic element in the 5'-untranslated region of AR. The negative regulation was abrogated when NF-B activity was inhibited by a superrepressor of the inhibitory B protein. In contrast, androgen-independent C4-2 (LNCaP-derived) cells fail to show AR down-regulation by TNF, despite expression of B-myb and TNF-induced NF-B activity similar to that in LNCaP cells. The negatively regulated AR gene chromatin region showed TNF-dependent enrichment of B-myb and the NF-B proteins p65 and p50. In parallel, the histone deacetylase 1, corepressor silencing mediator of retinoid and thyroid hormone receptor and the corepressor-associated scaffold protein mSin3A were recruited to the inhibitory site. In C4-2 cells, neither NF-B and B-myb, nor any of the corepressor components, were detected at the negative site in response to TNF. Apoptosis was induced in TNF-treated LNCaP cells, likely in part due to the down-regulation of AR. The androgen-independent, AR-expressing C4-2 and C4-2B (derived from C4-2) cells were resistant to TNF-induced apoptosis. The results linking androgen dependence to the NF-B and AR pathways may be insightful in identifying novel treatment targets for prostate cancer.

NURSA Molecule Pages Link:

Nuclear Receptors:   AR

Coregulators:   Sin3A  |  HDAC1  |  SMRT

This article has been cited by other articles:

				L. Shi, S. Ko, S. Kim, I. Echchgadda, T.-S. Oh, C. S. Song, and B. Chatterjee Loss of Androgen Receptor in Aging and Oxidative Stress through Myb Protooncoprotein-regulated Reciprocal Chromatin Dynamics of p53 and Poly(ADP-ribose) Polymerase PARP-1 J. Biol. Chem., December 26, 2008; 283(52): 36474 - 36485. [Abstract] [Full Text] [PDF]